Whooping cough bacterium evolves in Australia

Gram stain of the bacteria Bordetella pertussis. Credit: CDC

The bacterium that causes whooping cough, Bordetella pertussis, has changed in Australia - most likely in response to the vaccine used to prevent the disease - with a possible reduced effectiveness of the vaccine as a result, a new study shows.

A UNSW-led team of researchers analysed strains of Bordetella pertussis from across Australia and found that many strains no longer produce a key surface protein called pertactin.

About 80 per cent of the 2012 cases in Australia studied by the team were caused by pertactin-free strains. Pertactin is one of the three proteins, made from purified extracts of Bordetella pertussis bacteria, which are present in the currently used in Australia. The other two are toxin and filamentous haemagglutinin.

"It's like a game of hide and seek. It is harder for the antibodies made by the body's immune system in response to vaccination to 'search and destroy' the whooping cough bacteria which lack pertactin," says the senior author of the study, Associate Professor Ruiting Lan, of the UNSW School of Biotechnology and Biomolecular Sciences.

"This could mean that these pertactin-free strains have gained a selective advantage over bacterial strains with the pertactin protein."

The study is published in the journal Emerging Infectious Diseases.

Australia has only recently emerged from an epidemic of whooping cough that went on for an unusually long period – with about 142,000 cases from 2008 to 2012. Although the number of cases identified was greatly increased by more and better testing, the epidemic was still a major one. Nine babies died of whooping cough during the five years.

The research, led by UNSW PhD student Connie Lam, involved the analysis of 320 bacteria samples from patients with whooping cough obtained during 2008-2012 from five states – NSW, Victoria, Queensland, South Australia and Western Australia.

The proportion of pertactin-free bacteria rose from five per cent of cases tested in 2008 to 78 per cent in 2012. Pertactin-free strains of pertussis have also been detected overseas, including in countries such as France and the United States.

"The fact that they have arisen independently in different countries suggests this is in response to the vaccine," says Associate Professor Lan.

There is no evidence that the pertactin-free strains are more harmful than other , and it is not yet clear whether they reduce the effectiveness of the vaccine in the short or long term.

"More studies are needed to better understand the effects of vaccination on the evolution of the organism," says Associate Professor Lan.

The current acellular vaccine, purified down to three antigens, was introduced in 1997 to replace the previous whole-cell vaccine, after side effects such as fever and crying dissuaded many parents from starting or completing the three doses of vaccine required by six months of age.

"The acellular pertussis vaccine produces antibodies against pertussis toxin which is the main cause of severe disease symptoms produced by the whooping cough bacterium. Vaccination is still the only way to protect against whooping cough, especially for the youngest babies who are most at risk of severe illness," stressed Associate Professor Lan.

Babies need to be immunised at six to eight weeks of age, four months and six months, with a booster at four years.

add to favorites email to friend print save as pdf

Related Stories

Whooping cough boosters lack punch

Apr 08, 2014

Whooping cough vaccine protects infants and young children but booster doses wear off quickly, according to University of Queensland researchers.

Whooping cough vaccine may be losing its punch: study

Feb 10, 2010

(PhysOrg.com) -- Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found. A team of Australian scientists has ...

Recommended for you

UN says Syria vaccine deaths was an NGO 'mistake'

9 hours ago

The recent deaths of Syrian children after receiving measles vaccinations was the result of a "mistake" by a non-governmental partner who mixed in a muscle relaxant meant for anesthesia, a spokesman for the U.N. secretary-general ...

First US child dies from enterovirus D68

9 hours ago

A child in the northeastern US state of Rhode Island has become the first to die from an ongoing outbreak of a respiratory virus, enterovirus D68, health officials said Wednesday.

US Ebola patient had contact with kids: governor

9 hours ago

A man who was diagnosed with Ebola in virus in Texas came in contact with young children, and experts are monitoring them for any signs of disease, governor Rick Perry said Wednesday.

UN worker dies of suspected Ebola in Liberia

10 hours ago

The United Nations mission in Liberia announced on Wednesday the first suspected victim among its employees of the deadly Ebola epidemic ravaging the impoverished west African nation.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Modernmystic
5 / 5 (2) Apr 15, 2014
We wiped out small pox with a concerted global effort...and now we have to deal with this.

I appriciate all the work of the people in the lab and field dealing with infectious disease, but if you do an 99% effective job here it isn't good enough. Herd immunity won't eradicate anything and when we have vaccines that are capable of that, then that's what we should be about in my opinion. Go the extra mile and move on to the next one.